TL;DR
CTAB-P3HT/FA nanoparticles are established as a cost-effective, robust, and versatile theranostic platform for precision oncology and extend to other FR-overexpressing cancers, such as ovarian and lung cancers.
These innovative biopolymer‐based DDSs demonstrate considerable potential in enhancing the therapeutic efficacy of 5‐ALA and improving PDT outcomes, setting the stage for future advancements in targeted cancer therapies.
Thiolated chitosan nanoparticles are highlighted as a promising redox-responsive platform for delivering gold-based metallodrugs, expanding therapeutic strategies for the treatment of triple-negative breast cancer.
Enhanced efficacy is attributed to the synergistic action of butyric acid as a histone deacetylase inhibitor (HDACi), which complements curcumin’s anticancer activity.
The potential of CP–NM hybrid platforms to drive next-generation approaches for early cancer detection, therapeutic monitoring, and personalized healthcare is emphasized, focusing on material design strategies, sensing mechanisms, and representative applications across electrochemical, optical, and mechanical modalitie...
Early diagnosis of ovarian cancer remains a major clinical challenge. Human epididymis protein 4 (HE4) has emerged as a promising biomarker for early OC detection. To address limitations of existing HE4 quantification methods, we developed a nano-optical biosensor based on a luminescent europium-thiosemicarbazide (Eu-T...
Pullulan-stabilized gold nanoparticles (AuNPs) have been used extensively in the transdermal delivery system; however, the weakness is the low penetrability through the skin which decreased intracellular amount of active pharmaceutical ingredient (API). This research focused on the surface modification of AuNPs using a...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
